Article
Complex structural variations functionally inactivate the telomerase chaperone TCAB1 in osteosarcoma.
BMC cancer - 4 Jun 2026
Keegan Joshua, Sorbello Sydney, Mori Joakin, Muratani Shugo, Leshchiner Ignaty, Heaphy Christopher M, Flynn Rachel L
Abstract excerpt
Activation of the alternative lengthening of telomeres (ALT) pathway accounts for cellular immortalization in 75% of pediatric osteosarcoma. ALT does not rely on a single enzyme but instead, catalyzes telomere elongation via homologous recombination. There has been steady progress in defining the mechanisms that regulate the ALT pathway. However, the spectrum of genetic mutations that underlie activation of ALT...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
